Skip to the guide

Care questionLongevity care guide

Show guide index

Guide index

Find care

- Start here

- Find a search route

- Read reviews carefully

- Ask for a referral

- Use a board search

- Check the name

- Check the pharmacy

- Online or in person

- A visit by screen

- A visit in a room

- When states differ

Understand treatment

- Sort the medicine terms

- Medicine made to order

- Weight medicine questions

- Ask about treatment offers

Plan the bill

- What care can cost

- Insurance and cash routes

Ask and check

- When to pause

- Questions for the visit

- Read the source records

The care guideUnderstand treatment

Understand treatment / guidebook

# What kind of medicine is being discussed?

Get the exact name. Then ask which set of rules applies.

## Peptide is a description, not a treatment plan

A peptide is a substance made of a short chain of tiny parts joined together; insulin is one example.

Think of the links in a short chain. The word describes how the substance is put together, rather than what it would do for you.

The label peptide says nothing about a product’s permission for use as medicine as of September 2026.

Ask for the name of the actual medicine, rather than accepting peptide therapy as the whole explanation.

## Ask whether it is an approved product

The semaglutide brands Ozempic and Wegovy, alongside the tirzepatide brands Mounjaro and Zepbound, have products approved by the FDA for particular health problems, including diabetes and weight management, as of September 2026.

Ozempic and Mounjaro are used for type 2 diabetes; Wegovy and Zepbound are used for weight management.

FDA means the US Food and Drug Administration. Ask which product, which form, and which condition the proposed treatment is for. A conversation about longevity still needs those details.

## Ask whether it is made to order

Compounding is preparing a medicine to order through a pharmacist, physician, or registered facility.

A compounded medicine receives neither FDA approval nor the agency’s review before sale, as of September 2026.

Have the clinician explain why the need under discussion could not be met by an approved product.

## A bottle saying for research use only is not a care plan

As of September 2026, FDA warning letters describe sellers promoting products for human treatment while labelling them not for human consumption or for research use only.

In those letters, the FDA treated the products as unapproved medicines despite the wording on the labels.

Those words describe a product offered for laboratory work. They do not give you instructions for treatment. If a bottle has that label, ask a licensed clinician about a medicine intended for patient care.

The letters state the FDA’s concerns about named sellers. A court has not settled those concerns just because a letter was sent.

Read and check

## Source records

- Food and Drug Administration: compounding explained

- Food and Drug Administration: weight medicine concerns

- Semaglutide (Wegovy): product information

- Tirzepatide (Mounjaro): product information

Keep readingMedicine made to order

This guide helps you find words for care questions; it operates no clinic and sells no treatment.

Start hereQuestions for careSource recordsRead as text